Testing a new migraine pill for quick relief
Part of Brain & nervous system clinical trials.
This study tests an experimental tablet, BR005-036C, to see if it safely and effectively stops migraine attacks in adults. If you have migraines, this could offer a new option for fast relief when a headache starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had migraine headaches (with or without aura) for at least 1 year, and they started before age 50.
- In the last 3 months, you had 2 to 8 migraine attacks per month, but fewer than 15 headache days per month.
- If you take daily migraine prevention medicine, your dose has been stable for at least 3 months.
- You do not have certain other headache types (like hemiplegic migraine or cluster headaches) or serious health problems.
- You have not used certain migraine treatments (like gepants or CGRP antibody injections) recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This study tests a new medication called NB001 to help stop migraine headaches when they happen. Researchers want to see if it works better than current treatments for people who have frequent migraines.
This trial is testing new ways to treat migraine attacks. It is for adults in Denmark who have migraine on a few days each month and have used triptan rescue medicines.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.
Hear when a new Migraine, With or Without Aura trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.